We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Sonic Healthcare Limited | ASX:SHL | Australian Stock Exchange | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.13 | -0.47% | 27.61 | 27.61 | 27.70 | 27.98 | 27.61 | 27.96 | 566,246 | 07:50:00 |
From Jan 2023 to Jan 2025
By Stuart Condie
SYDNEY--Australian pathology services provider Sonic Healthcare Ltd. agreed to pay 190 million euros (US$206.0 million) to acquire German laboratory chain Diagnosticum.
Sonic on Monday said that founder-led Diagnosticum, which operates 15 laboratories and employs 25 pathologists, is expected to generate 65 million euros of revenue in the 2024 fiscal year. Sonic reported 4.08 billion Australian dollars (US$2.73 billion) of revenue in 1H of fiscal 2023.
The all-cash acquisition is not material but will immediately be earnings-per-share accretive when it closes before the end of the 2023 calendar year, Sonic said. The majority of the purchase price is tax deductible in Germany over 15 years as goodwill amortization, it added.
Write to Stuart Condie at stuart.condie@wsj.com
(END) Dow Jones Newswires
April 02, 2023 19:34 ET (23:34 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Sonic Healthcare Chart |
1 Month Sonic Healthcare Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
